Quantum computing is revolutionizing pharmaceutical research by leveraging artificial intelligence to accelerate drug discovery. However, this integration raises significant ethical concerns, including biased algorithms that may perpetuate existing health disparities. The lack of transparency and explainability in AI decision-making processes can also lead to errors or biases with serious consequences. Furthermore, intellectual property and ownership issues arise when AI systems generate new ideas and insights. As researchers increasingly rely on AI-assisted research, there is a risk of displacing human researchers or diminishing their contributions. Additionally, data privacy and security concerns must be addressed to safeguard against potential breaches.
↧